No abstract

IntroductionDual diagnosis is a growing problem in Western society, despite which there are no large studies examining this issue, nor specific protocols to address them.ObjectivesTo raise awareness of the importance of dual diagnosis both its prevalence and special features that presents need a different performance plan from them separately.MethodsComprehensive literature review of all published in the last 2 years, as well as the specific features.ConclusionDual diagnosis has very specific characteristics that we must know in order to develop therapeutic strategies adapted to the present conditions.Disclosure of interestThe authors have not supplied their declaration of competing interest.

IntroductionSuicide in the elderly is a growing problem in Western society, despite which there are no large studies examining this issue, nor specific protocols to address them.ObjectiveTo raise awareness of the importance of suicidal behavior in elderly both its prevalence and special features that presents need a different performance plan from other fractions old.MethodsComprehensive literature review of all published in the last two years, as well as the specific features.ConclusionSuicidal behavior in the elderly has very specific characteristics that we must know in order to develop therapeutic strategies adapted to the present conditions.Disclosure of interestThe authors have not supplied their declaration of competing interest.

IntroductionThe extended release injectable offers a good alternative for those patients with no or poor adherence to treatment. Numerous studies indicate that decrease the number of relapses in such individuals. Our aim is to check whether a group of our patients diagnosed with dual pathology coincide with these data.MethodsWe followed a group of 5 patients diagnosed with paranoid schizophrenia or delusional disorder with drug consumption in the last year. We measured the number of relapses, understood as the number of visits to emergency and outpatient devices Mental Health Hospitals and hospitalizations six months before the start of treatment with aripiprazole injectable extended release and six months after.ResultsThe preliminary results point to a significant reduction in the number of emergency room visits and hospitalizations after starting sustained release injectable treatment.ConclusionsOur preliminary results are consistent with the literature, we found also reduced consumption of toxic and better adherence to drug addiction devices. The new antipsychotics extended release is a good alternative for patients with dual diagnosis.Disclosure of interestThe authors have not supplied their declaration of competing interest.

ObjectiveTo demonstrate the therapeutic efficacy of aripiprazole LP by a case of difficult clinical management and that we often find in our daily practice.MethodsDescription of a clinical case of a 21-year-old man, recently diagnosed with paranoid schizophrenia with no awareness of disease neither treatment adherence and harmful use of THC and cocaine that are identified as precipitating factors for multiple hospital admissions.ResultsInjectable medication with objective clinical improvement is significant, cessation of readmissions, achieving improvement in all parameters measured functionality and proper adherence to treatment as well as outpatient mental health of both devices as of drug dependence.ConclusionPsychiatry is facing the great challenge of modifying the natural history to the deterioration of schizophrenia, a disease considered one of the leading causes of years lived with disability. The objectives medium and long-term treatment of this disease are centered on the delay-avoidance disability and improving the functioning and quality of life of people with this disease.Disclosure of interestThe authors have not supplied their declaration of competing interest.